- GlycoVHH : optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery(2023)
Auteurs: Loes van Schie, Wander Van Breedam, Charlotte Roels, Martin Frank, Ahmadreza Mehdipour, Bram Laukens, Wim Nerinckx, Francis Santens, Simon Devos, Iebe Rossey, et al.
- How RSV proteins join forces to overcome the host innate immune response(2022)
Auteurs: Tessa Van Royen, Iebe Rossey
- A vulnerable, membrane-proximal site in human respiratory syncytial virus F revealed by a prefusion-specific single-domain antibody(2021)
Auteurs: Iebe Rossey, Ching-Lin Hsieh, Marlies Ballegeer, Jason S. McLellan, Rebecca Ellis Dutch
- Vaccines against human respiratory syncytial virus in clinical trials, where are we now?(2019)
Auteurs: Iebe Rossey
Pagina's: 1053 - 1067
- Clinical potential of prefusion RSV F-specific antibodies(2018)
Auteurs: Iebe Rossey, Jason S McLellan
Pagina's: 209 - 219
- Single-domain antibodies and their formatting to combat viral infections(2018)
Auteurs: Dorien De Vlieger, Marlies Ballegeer, Iebe Rossey
- Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state(2017)
Auteurs: Iebe Rossey, Morgan SA Gilman, Stephanie C Kabeche, Daniel Wrapp, Masaru Kanekiyo, Man Chen, Vicente Mas, Jan Spitaels, José A Melero, Barney S Graham, et al.
- New antivirals against respiratory syncytial virus
Auteurs: Iebe Rossey
- CD8U+207A T cell immunity against human respiratory syncytial virus
Auteurs: Iebe Rossey, Sarah De Baets
Pagina's: 6130 - 6137
